Safety and efficacy of the peptide-based therapeutic vaccine for HIV-1, Vacc-4×: a phase 2 randomised, double-blind, placebo-controlled trial

The Lancet Infectious Diseases ◽

10.1016/s1473-3099(13)70343-8 ◽

2014 ◽

Vol 14 (4) ◽

pp. 291-300 ◽

Author(s):

Richard B Pollard ◽

Jürgen K Rockstroh ◽

Giuseppe Pantaleo ◽

David M Asmuth ◽

Barry Peters ◽

...

Keyword(s):

Controlled Trial ◽

Therapeutic Vaccine ◽

Phase 2 ◽

Double Blind ◽

Safety And Efficacy ◽

Double Blind Placebo ◽

Download Full-text

OA04-01. Safety and immunogenicity of LIPO-5, a HIV-1 lipopeptide vaccine: results of ANRS VAC18, a phase 2, randomized, double-blind, placebo-controlled trial

Retrovirology ◽

10.1186/1742-4690-6-s3-o25 ◽

2009 ◽

Vol 6 (S3) ◽

Author(s):

D Salmon-Céron ◽

C Durier ◽

C Desaint ◽

Cuzin ◽

M Surenaud ◽

...

Keyword(s):

Controlled Trial ◽

Phase 2 ◽

Double Blind ◽

Double Blind Placebo ◽

Download Full-text

“Protocol for a phase 2, randomized, double-blind, placebo-controlled, safety and efficacy study of dutogliptin in combination with filgrastim in early recovery post-myocardial infarction”: study protocol for a randomized controlled trial

Trials ◽

10.1186/s13063-020-04652-0 ◽

2020 ◽

Vol 21 (1) ◽

Author(s):

Dirk von Lewinski ◽

◽

Joseph B. Selvanayagam ◽

Richard A. Schatz ◽

Bernd Jilma ◽

...

Keyword(s):

Myocardial Infarction ◽

Randomized Controlled Trial ◽

Controlled Trial ◽

Efficacy Study ◽

Phase 2 ◽

Early Recovery ◽

Double Blind ◽

Safety And Efficacy ◽

Double Blind Placebo ◽

Randomized Controlled

Download Full-text

Faculty Opinions recommendation of Safety and efficacy of NA-1 in patients with iatrogenic stroke after endovascular aneurysm repair (ENACT): a phase 2, randomised, double-blind, placebo-controlled trial.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.717961804.793464512 ◽

2012 ◽

Author(s):

Nicolas Bruder

Keyword(s):

Controlled Trial ◽

Endovascular Aneurysm Repair ◽

Phase 2 ◽

Double Blind ◽

Safety And Efficacy ◽

Double Blind Placebo ◽

Aneurysm Repair

Download Full-text

Safety and efficacy of zinc supplementation for children with HIV-1 infection in South Africa: a randomised double-blind placebo-controlled trial

10.1016/s0140-6736(05)67756-2 ◽

2005 ◽

Vol 366 (9500) ◽

pp. 1862-1867 ◽

Author(s):

Raziya Bobat ◽

Hoosen Coovadia ◽

Cindy Stephen ◽

Kimesh L Naidoo ◽

Neil McKerrow ◽

...

Keyword(s):

South Africa ◽

Zinc Supplementation ◽

Controlled Trial ◽

Double Blind ◽

Safety And Efficacy ◽

Double Blind Placebo ◽

Download Full-text

Safety and efficacy of transplantation of nurown (autologous mesenchymal stromal cells secreting neurotrophic factors) in patients with ALS: A phase 2 randomized double blind placebo controlled trial

Cytotherapy ◽

10.1016/j.jcyt.2017.02.040 ◽

2017 ◽

Vol 19 (5) ◽

pp. S23 ◽

Author(s):

Y. Gothelf ◽

M. Cudkowicz ◽

J. Berry ◽

A. Windebank ◽

N. Staff ◽

...

Keyword(s):

Mesenchymal Stromal Cells ◽

Stromal Cells ◽

Neurotrophic Factors ◽

Controlled Trial ◽

Phase 2 ◽

Double Blind ◽

Safety And Efficacy ◽

Double Blind Placebo

Download Full-text

Faculty Opinions recommendation of Safety and efficacy of NA-1 in patients with iatrogenic stroke after endovascular aneurysm repair (ENACT): a phase 2, randomised, double-blind, placebo-controlled trial.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.717961804.793478082 ◽

2013 ◽

Author(s):

Mishiya Matsumoto

Keyword(s):

Controlled Trial ◽

Endovascular Aneurysm Repair ◽

Phase 2 ◽

Double Blind ◽

Safety And Efficacy ◽

Double Blind Placebo ◽

Aneurysm Repair

Download Full-text

Safety and efficacy of VRC01 broadly neutralising antibodies in adults with acutely treated HIV (RV397): a phase 2, randomised, double-blind, placebo-controlled trial

The Lancet HIV ◽

10.1016/s2352-3018(19)30053-0 ◽

2019 ◽

Vol 6 (5) ◽

pp. e297-e306 ◽

Author(s):

Trevor A Crowell ◽

Donn J Colby ◽

Suteeraporn Pinyakorn ◽

Carlo Sacdalan ◽

Amélie Pagliuzza ◽

...

Keyword(s):

Controlled Trial ◽

Phase 2 ◽

Neutralising Antibodies ◽

Double Blind ◽

Safety And Efficacy ◽

Double Blind Placebo

Download Full-text

Safety and efficacy of NA-1 in patients with iatrogenic stroke after endovascular aneurysm repair (ENACT): a phase 2, randomised, double-blind, placebo-controlled trial

The Lancet Neurology ◽

10.1016/s1474-4422(12)70225-9 ◽

2012 ◽

Vol 11 (11) ◽

pp. 942-950 ◽

Author(s):

Michael D Hill ◽

Renee H Martin ◽

David Mikulis ◽

John H Wong ◽

Frank L Silver ◽

...

Keyword(s):

Controlled Trial ◽

Endovascular Aneurysm Repair ◽

Phase 2 ◽

Double Blind ◽

Safety And Efficacy ◽

Double Blind Placebo ◽

Aneurysm Repair

Download Full-text

A Phase 2, Randomized, Double-Blind, Placebo-Controlled Trial to Evaluate Reduction in Inflammation in Patients With Advanced Chronic Renal Disease Utilizing Antibody Mediated IL-6 Inhibition

Case Medical Research ◽

10.31525/ct1-nct03926117 ◽

2019 ◽

Author(s):

Keyword(s):

Renal Disease ◽

Chronic Renal Disease ◽

Controlled Trial ◽

Phase 2 ◽

Double Blind ◽

Double Blind Placebo

Download Full-text

Faculty Opinions recommendation of Efficacy and safety of TMC125 (etravirine) in treatment-experienced HIV-1-infected patients in DUET-1: 24-week results from a randomised, double-blind, placebo-controlled trial.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.1088945.542078 ◽

2007 ◽

Author(s):

Jonathan Schapiro

Keyword(s):

Controlled Trial ◽

Efficacy And Safety ◽

Double Blind ◽

Double Blind Placebo ◽

Download Full-text